| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
CYSTIC FIBROSIS |
1 Laboratory of Microbiology, Ghent University, Ghent, Belgium
2 Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA
Correspondence to:
Correspondence to:
Dr T Coenye
Laboratory of Microbiology, Ghent University, K L Ledeganckstraat 35, B-9000 Ghent, Belgium; Tom.Coenye{at}ugent.be
Background: Burkholderia cenocepacia can cause life threatening respiratory tract infections in patients with cystic fibrosis (CF) and has a significant impact on survival. There is extensive evidence for patient to patient spread and nosocomial transmission of this organism, and several widespread B cenocepacia strains have been described including the transatlantic ET12 clone. A study was performed to compare B cenocepacia isolates recovered from CF patients receiving care in several European countries and strains isolated from other clinical samples and the environment, with reference isolates from the epidemic B cenocepacia strain PHDC which has so far only been recovered from CF patients and soil in the USA.
Methods: A large collection of B cenocepacia isolates, including a large number recovered from CF patients receiving care in several European countries, Canada and the USA, were genotyped by means of randomly amplified polymorphic DNA typing (RAPD) and rep-PCR using the BOX-A1R primer (BOX-PCR).
Results: Nineteen Burkholderia cenocepacia isolates cultured from clinical samples in Europe (18 recently recovered from CF patients in France and Italy and one recovered in 1964 from urine in the UK) showed RAPD fingerprinting patterns that were similar to patterns obtained from isolates of B cenocepacia strain PHDC. Subsequent analysis of these isolates using BOX-PCR confirmed that the European isolates and strain PHDC represent the same clone.
Conclusion: Strain PHDC represents a second transatlantic B cenocepacia clone capable of colonising patients with CF.
Keywords: cystic fibrosis; Burkholderia cepacia complex
Related Article
Thorax 2004 59: 913.
This article has been cited by other articles:
|
|
 |
|
  E. Vanlaere, J. J. LiPuma, A. Baldwin, D. Henry, E. De Brandt, E. Mahenthiralingam, D. Speert, C. Dowson, and P. Vandamme Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex Int J Syst Evol Microbiol, July 1, 2008; 58(7): 1580 - 1590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. De Soyza, A. Silipo, R. Lanzetta, J. R. Govan, and A. Molinaro Review: Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides Innate Immunity, June 1, 2008; 14(3): 127 - 144. [Abstract] [PDF]
|
|
|
|
 |
|
 M. A. Schell, L. Lipscomb, and D. DeShazer Comparative Genomics and an Insect Model Rapidly Identify Novel Virulence Genes of Burkholderia mallei J. Bacteriol., April 1, 2008; 190(7): 2306 - 2313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Bernier, D. T. Nguyen, and P. A. Sokol A LysR-Type Transcriptional Regulator in Burkholderia cenocepacia Influences Colony Morphology and Virulence Infect. Immun., January 1, 2008; 76(1): 38 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Baldwin, E. Mahenthiralingam, P. Drevinek, C. Pope, D. J. Waine, D. A. Henry, D. P. Speert, P. Carter, P. Vandamme, J. J. LiPuma, et al. Elucidating Global Epidemiology of Burkholderia multivorans in Cases of Cystic Fibrosis by Multilocus Sequence Typing J. Clin. Microbiol., January 1, 2008; 46(1): 290 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Turton, N. Arif, D. Hennessy, M. E. Kaufmann, and T. L. Pitt Revised Approach for Identification of Isolates within the Burkholderia cepacia Complex and Description of Clinical Isolates Not Assigned to Any of the Known Genomovars J. Clin. Microbiol., September 1, 2007; 45(9): 3105 - 3108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Campana, G. Taccetti, N. Ravenni, F. Favari, L. Cariani, A. Sciacca, D. Savoia, A. Collura, E. Fiscarelli, G. De Intinis, et al. Transmission of Burkholderia cepacia Complex: Evidence for New Epidemic Clones Infecting Cystic Fibrosis Patients in Italy J. Clin. Microbiol., October 1, 2005; 43(10): 5136 - 5142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Bernier and P. A. Sokol Use of Suppression-Subtractive Hybridization To Identify Genes in the Burkholderia cepacia Complex That Are Unique to Burkholderia cenocepacia J. Bacteriol., August 1, 2005; 187(15): 5278 - 5291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Drevinek, S. Vosahlikova, O. Cinek, V. Vavrova, J. Bartosova, P. Pohunek, and E. Mahenthiralingam Widespread clone of Burkholderia cenocepacia in cystic fibrosis patients in the Czech Republic J. Med. Microbiol., July 1, 2005; 54(7): 655 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 New bacteria in cystic fibrosis Arch. Dis. Child., May 1, 2005; 90(5): 444 - 444. [Full Text] [PDF]
|
|
|
|
 |
|
 J S Elborn Difficult bacteria, antibiotic resistance and transmissibility in cystic fibrosis Thorax, November 1, 2004; 59(11): 914 - 915. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
